![Rick Pollack, American Hospital Association CEO and President standing in front of United States flag and the AHA seal.](/sites/default/files/2022-04/AT-Rick-Pollack-Perspective-2022-News-900x400.jpg)
The House Energy and Commerce Oversight and Investigations subcommittee June 4 hosted a hearing to discuss oversight of the 340B Drug Pricing Program. AHA sent a letter to the subcommittee for the hearing, urging Congress to protect the program and highlighted its value to hospitals and health systems.